Methylene blue for CPB [12]

Anesthesia and Analgesia

Volumn 104, Issue 5, 2007, Pages 1296-1297

  Maslow, Andrew D ^a   Schwartz, Carl S ^a   Stearns, Gary ^a   Batula, Parag ^b   Gough, Jeffrey ^a   Singh, Arun K ^a  

^a Department of Anesthesiology ^*

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE;

CARDIOPULMONARY BYPASS; DRUG EFFECT; HEMODYNAMICS; HUMAN; LETTER; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; VASOPLEGIA;

EID: 34247465444     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000260368.21463.df     Document Type: Letter

References (5)

1. Valchanov K, Falter F. Methylene blue for CPB. Anesth Analg 2007;104:1296.
2. Maslow AD, Stearns G, Batula P, et al. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg 2006;103:2-8.
3. Leyh RG, Kofidis T, Struber M, et al. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg 2003;125:1426-31.
4. Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004;77:496-9.
5. Ozal E, Kuralay E, Yildirim V, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg 2005;79:1615-9.